title: Activation of blood coagulation in cancer: implications for tumour progression.
abstract: Several studies have suggested a role for blood coagulation proteins in tumour progression. Herein, we discuss (1) the activation of the blood clotting cascade in the tumour microenvironment and its impact on primary tumour growth; (2) the intravascular activation of blood coagulation and its impact on tumour metastasis and cancer-associated thrombosis; and (3) antitumour therapies that target blood-coagulation-associated proteins. Expression levels of the clotting initiator protein TF (tissue factor) have been correlated with tumour cell aggressiveness. Simultaneous TF expression and PS (phosphatidylserine) exposure by tumour cells promote the extravascular activation of blood coagulation. The generation of blood coagulation enzymes in the tumour microenvironment may trigger the activation of PARs (protease-activated receptors). In particular, PAR1 and PAR2 have been associated with many aspects of tumour biology. The procoagulant activity of circulating tumour cells favours metastasis, whereas the release of TF-bearing MVs (microvesicles) into the circulation has been correlated with cancer-associated thrombosis. Given the role of coagulation proteins in tumour progression, it has been proposed that they could be targets for the development of new antitumour therapies.
authors.forename: Luize G
authors.initials: LG
authors.lastname: Lima
authors.affiliation: *Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Robson Q
authors.initials: RQ
authors.lastname: Monteiro
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001777:Blood Coagulation; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors / Q000502:physiology; D018450:Disease Progression; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000473:pathology
chemical_list: D000925:Anticoagulants; D000970:Antineoplastic Agents; D001779:Blood Coagulation Factors
references.citation: Thromb Haemost. 2001 Jul;86(1):334-45
references.pmid: 11487022
references.citation: Acta Haematol. 2001;106(1-2):6-12
references.pmid: 11549771
references.citation: Nat Med. 2004 May;10(5):502-9
references.pmid: 15098027
references.citation: Cancer Res. 2006 Jan 1;66(1):307-14
references.pmid: 16397244
references.citation: J Biol Chem. 1993 Jul 15;268(20):14586-9
references.pmid: 8325838
references.citation: Blood. 2007 Jul 1;110(1):133-41
references.pmid: 17371949
references.citation: Thromb Haemost. 2011 Oct;106(4):712-23
references.pmid: 21800005
references.citation: Matrix Biol. 2000 Aug;19(4):345-51
references.pmid: 10963995
references.citation: J Biol Chem. 2004 May 28;279(22):23038-44
references.pmid: 15039423
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8663-8
references.pmid: 10411932
references.citation: J Thromb Haemost. 2009 Nov;7(11):1855-64
references.pmid: 19624457
references.citation: J Thromb Haemost. 2003 Jul;1(7):1495-503
references.pmid: 12871285
references.citation: Cancer Res. 1991 Sep 1;51(17):4549-56
references.pmid: 1873799
references.citation: Thromb Haemost. 1995 Jul;74(1):278-81
references.pmid: 8578472
references.citation: Int J Oncol. 2003 Feb;22(2):295-300
references.pmid: 12527925
references.citation: Blood. 2000 Jul 1;96(1):170-5
references.pmid: 10891447
references.citation: J Thromb Haemost. 2005 Aug;3(8):1800-14
references.pmid: 16102047
references.citation: Cancer Cell. 2006 Nov;10(5):355-62
references.pmid: 17097558
references.citation: Oncol Rep. 2009 Jun;21(6):1599-604
references.pmid: 19424642
references.citation: Blood. 2012 Jan 26;119(4):924-32
references.pmid: 22065595
references.citation: Blood. 1984 Jul;64(1):177-84
references.pmid: 6733271
references.citation: Blood. 1998 Nov 15;92(10):3694-700
references.pmid: 9808563
references.citation: Cancer. 1980 May 1;45(9):2374-82
references.pmid: 7379034
references.citation: J Biol Chem. 2011 Jan 14;286(2):1429-35
references.pmid: 21059650
references.citation: J Thromb Haemost. 2007 Mar;5(3):632-4
references.pmid: 17319909
references.citation: Blood. 2002 May 15;99(10):3602-12
references.pmid: 11986214
references.citation: Crit Rev Oncol Hematol. 2003 Oct;48(1):65-80
references.pmid: 14585484
references.citation: Thromb Res. 2007;120 Suppl 2:S22-8
references.pmid: 18023710
references.citation: Oncotarget. 2011 Jan-Feb;2(1-2):8-17
references.pmid: 21378407
references.citation: Cancer Res. 2004 Dec 1;64(23):8613-9
references.pmid: 15574768
references.citation: FASEB J. 1994 Apr 1;8(6):385-90
references.pmid: 8168689
references.citation: FASEB J. 2003 Feb;17(2):163-74
references.pmid: 12554695
references.citation: Biochem Biophys Res Commun. 2012 May 4;421(2):221-7
references.pmid: 22497886
references.citation: Protein Sci. 2008 Jan;17(1):146-53
references.pmid: 18042685
references.citation: PLoS One. 2011;6(9):e25103
references.pmid: 21966428
references.citation: N Engl J Med. 2000 Dec 21;343(25):1846-50
references.pmid: 11117976
references.citation: Blood. 2012 Mar 29;119(13):3164-75
references.pmid: 22327225
references.citation: Mol Cell Biol. 1995 Feb;15(2):704-10
references.pmid: 7823939
references.citation: Blood. 2007 Sep 15;110(6):1723-9
references.pmid: 17496204
references.citation: J Thromb Haemost. 2007 Jul;5 Suppl 1:246-54
references.pmid: 17635733
references.citation: Kidney Int. 2002 Nov;62(5):1757-63
references.pmid: 12371977
references.citation: Thromb Res. 2005;115(1-2):123-9
references.pmid: 15567463
references.citation: Int J Cancer. 2005 Feb 20;113(5):752-60
references.pmid: 15499615
references.citation: Blood. 1983 Jul;62(1):14-31
references.pmid: 6407544
references.citation: J Thromb Haemost. 2007 Mar;5(3):520-7
references.pmid: 17166244
references.citation: J Exp Med. 2009 Aug 31;206(9):1913-27
references.pmid: 19667060
references.citation: Best Pract Res Clin Haematol. 2009 Mar;22(1):71-83
references.pmid: 19285274
references.citation: Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2185-98
references.pmid: 22796577
references.citation: Medicine (Baltimore). 1999 Sep;78(5):285-91
references.pmid: 10499070
references.citation: Semin Thromb Hemost. 2008 Mar;34(2):147-53
references.pmid: 18645919
references.citation: Blood. 2008 Jan 1;111(1):190-9
references.pmid: 17901245
references.citation: Clin Cancer Res. 2003 Nov 1;9(14):5339-45
references.pmid: 14614019
references.citation: Thromb Res. 2012 Jun;129(6):779-86
references.pmid: 21917301
references.citation: J Immunol. 1994 Oct 1;153(7):3245-55
references.pmid: 7522256
references.citation: Blood. 2004 Apr 15;103(8):3029-37
references.pmid: 15070680
references.citation: Thromb Haemost. 1995 May;73(5):793-7
references.pmid: 7482405
references.citation: Br J Haematol. 1975 Dec;31(4):449-60
references.pmid: 1242095
references.citation: Oncogene. 2009 Aug 27;28(34):3047-57
references.pmid: 19543320
references.citation: Br J Cancer. 1999 Feb;79(3-4):472-7
references.pmid: 10027315
references.citation: Best Pract Res Clin Haematol. 2009 Mar;22(1):61-9
references.pmid: 19285273
references.citation: Cancer Lett. 2009 Oct 8;283(2):168-75
references.pmid: 19401262
references.citation: Melanoma Res. 2009 Oct;19(5):301-8
references.pmid: 19550359
references.citation: Br J Cancer. 1999 Feb;79(3-4):401-6
references.pmid: 10027305
references.citation: Am J Hematol. 2002 Apr;69(4):247-54
references.pmid: 11921018
references.citation: Cancer Res. 2003 Jun 1;63(11):2997-3000
references.pmid: 12782609
references.citation: J Thromb Haemost. 2008 May;6(5):812-9
references.pmid: 18315549
references.citation: Blood Rev. 2001 Jun;15(2):61-7
references.pmid: 11409906
references.citation: J Thromb Haemost. 2007 Aug;5(8):1588-97
references.pmid: 17470200
references.citation: Blood. 2005 Feb 15;105(4):1734-41
references.pmid: 15494427
references.citation: J Clin Invest. 2003 Sep;112(6):853-62
references.pmid: 12975470
references.citation: Front Oncol. 2012 Sep 10;2:115
references.pmid: 22973557
references.citation: Cancer Res. 1985 Nov;45(11 Pt 1):5521-5
references.pmid: 4053025
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7742-7
references.pmid: 11438726
references.citation: Cancer Res. 1983 Sep;43(9):4434-42
references.pmid: 6347372
references.citation: Thromb Res. 2010 Apr;125 Suppl 2:S58-61
references.pmid: 20434007
references.citation: Science. 1981 May 22;212(4497):923-4
references.pmid: 7195067
references.citation: Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11832-6
references.pmid: 1465406
references.citation: Trends Cardiovasc Med. 2002 May;12(4):149-54
references.pmid: 12069753
references.citation: J Thromb Haemost. 2011 Jul;9 Suppl 1:306-15
references.pmid: 21781267
references.citation: Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):13076-81
references.pmid: 22826226
references.citation: Expert Rev Hematol. 2013 Feb;6(1):91-101
references.pmid: 23373784
references.citation: J Thromb Haemost. 2012 Sep;10(9):1849-58
references.pmid: 22823596
references.citation: Front Biosci. 2006 Jan 01;11:830-7
references.pmid: 16146774
references.citation: J Thromb Haemost. 2004 Nov;2(11):2065-7
references.pmid: 15550054
references.citation: Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):940-4
references.pmid: 12637343
references.citation: Front Oncol. 2012 Sep 06;2:110
references.pmid: 22973554
references.citation: Eur J Clin Invest. 2004 Jun;34(6):392-401
references.pmid: 15200490
references.citation: Cancer Res. 2008 Sep 1;68(17):7219-27
references.pmid: 18757438
references.citation: Cell. 2005 Feb 11;120(3):303-13
references.pmid: 15707890
references.citation: Cancer Res. 1991 Jun 1;51(11):3062-6
references.pmid: 2032247
references.citation: J Thromb Haemost. 2006 Jul;4(7):1546-52
references.pmid: 16839352
references.citation: Blood. 2011 Oct 13;118(15):4015-23
references.pmid: 21860019
references.citation: Blood. 2005 Jan 1;105(1):178-85
references.pmid: 15367435
references.citation: Semin Thromb Hemost. 1998;24(2):93-109
references.pmid: 9579631
references.citation: Blood. 2012 Jun 7;119(23):5543-52
references.pmid: 22547577
references.citation: J Thromb Haemost. 2008 Sep;6(9):1517-24
references.pmid: 18433463
references.citation: Thromb Haemost. 2007 Jan;97(1):119-23
references.pmid: 17200778
references.citation: Semin Immunopathol. 2011 Sep;33(5):455-67
references.pmid: 21318413
references.citation: Cancer Res. 2005 Feb 15;65(4):1406-13
references.pmid: 15735028
references.citation: Thromb Res. 2001 Jun 15;102(6):V215-24
references.pmid: 11516455
references.citation: Nature. 2000 Sep 14;407(6801):258-64
references.pmid: 11001069
references.citation: Biochem J. 2005 May 1;387(Pt 3):871-7
references.pmid: 15617517
references.citation: Blood. 2002 Nov 15;100(10):3484-8
references.pmid: 12393647
references.citation: Thromb Haemost. 2001 Sep;86(3):828-33
references.pmid: 11583315
references.citation: Clin Cancer Res. 2005 Apr 1;11(7):2531-9
references.pmid: 15814630
references.citation: Thromb Haemost. 1998 May;79(5):1041-7
references.pmid: 9609244
references.citation: Thromb Haemost. 2006 Jul;96(1):7-13
references.pmid: 16807644
references.citation: Clin Cancer Res. 2009 Nov 15;15(22):6830-40
references.pmid: 19861441
references.citation: J Thromb Haemost. 2004 Jan;2(1):93-101
references.pmid: 14717972
references.citation: Ann Hematol. 2008 Jun;87(6):451-7
references.pmid: 18292996
references.citation: Int J Cancer. 2010 May 15;126(10):2330-40
references.pmid: 19795460
references.citation: Thromb Res. 2012 Sep;130(3):e163-70
references.pmid: 22683021
references.citation: J Clin Invest. 1994 Sep;94(3):1320-7
references.pmid: 7521887
references.citation: J Thromb Haemost. 2006 May;4(5):1056-62
references.pmid: 16689759
references.citation: Circulation. 2000 Feb 29;101(8):841-3
references.pmid: 10694520
references.citation: Thromb Res. 2012 Apr;129 Suppl 1:S1-5
references.pmid: 22682116
references.citation: Blood Cells Mol Dis. 2011 Mar 15;46(3):230-4
references.pmid: 21216163
references.citation: Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3352-7
references.pmid: 11248082
references.citation: Blood. 2004 Jul 15;104(2):397-401
references.pmid: 15031212
references.citation: Thromb Haemost. 1991 May 6;65(5):545-8
references.pmid: 1871716
references.citation: Semin Thromb Hemost. 2006 Feb;32(1):54-70
references.pmid: 16479463
references.citation: Clin Cancer Res. 2007 May 15;13(10):2870-5
references.pmid: 17504985
references.citation: Br J Haematol. 1997 Mar;96(3):458-63
references.pmid: 9054648
references.citation: Crit Rev Oncol Hematol. 2007 May;62(2):126-36
references.pmid: 17293122
references.citation: Physiol Rev. 2004 Apr;84(2):579-621
references.pmid: 15044683
references.citation: Cancer Res. 2008 Dec 15;68(24):10068-76
references.pmid: 19074872
references.citation: Int J Cancer. 2008 Apr 1;122(7):1592-7
references.pmid: 18058798
references.citation: Thromb Haemost. 2001 Nov;86(5):1210-4
references.pmid: 11816709
references.citation: Blood. 1997 Feb 15;89(4):1121-32
references.pmid: 9028933
references.citation: Clin Cancer Res. 2009 Jan 1;15(1):208-16
references.pmid: 19118048
references.citation: Blood. 2010 Dec 23;116(26):6106-13
references.pmid: 20861457
references.citation: Blood Coagul Fibrinolysis. 2004 Oct;15(7):521-38
references.pmid: 15389118